IFNA2 and HIV-1 infection: To evaluate whether chronic HIV-1 infection durably suppresses the induction of IFN responses and HIV-1 restriction factors, we treated HIV-1-infected humanized mice with 1,000 IU/g/day exogenous recombinant IFN-α (rIFN-α) for five consecutive days.